Browsing Tag
Antengene
2 posts
Antengene’s XPOVIO approved in China for diffuse large B-cell lymphoma
Antengene Corporation Limited, a commercial-stage global biopharmaceutical company, has announced a significant milestone with the China National Medical…
July 5, 2024
Antengene receives approval for ATG-016 clinical trial in myelodysplastic syndrome
Antengene, a leading Chinese biopharmaceutical company, has announced a significant milestone with the approval of its Phase 1/2…
November 26, 2020